British supermarkets are experiencing their first decline in grocery sales volumes this year, with experts attributing part of this downturn to the rising popularity of weight-loss medications. Market research firm
Weightloss3- Page
41Articles
In an unprecedented shift within the underground pharmaceutical market, drug dealers across the UK are diversifying their offerings to include sought-after weight-loss medications alongside traditional illicit substances. The weight-loss injection
British online pharmacies have witnessed extraordinary growth, with some providers reporting up to 300% increase in demand, primarily driven by the surging popularity of weight-loss medications. Market analysis from SpendMapper
Recent clinical trials have unveiled a significant breakthrough in the potential application of weight-loss medication Semaglutide, marketed as Wegovy, in reducing alcohol consumption. The groundbreaking study demonstrated a remarkable 40%
Danish pharmaceutical giant Novo Nordisk has projected reduced growth for 2025 amidst mounting competition in the weight-loss drugs market from American rivals. The company, renowned for its obesity treatments Ozempic
The surging popularity of weight-loss medications is creating unprecedented ripples across the alcohol industry, with major beverage companies facing potential long-term revenue challenges. Investment heavyweight Terry Smith’s recent divestment from
Weight Loss Drugs Show Promise in Reducing Alzheimers Risk and Other Health Conditions Study Reveals
A groundbreaking study involving 215,000 US military veterans with diabetes has revealed that popular weight-loss medications demonstrate a 12 per cent reduction in Alzheimer’s disease risk, whilst simultaneously highlighting increased
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a “wild west” approach to pharmaceutical promotion.
In a remarkable feat, Eli Lilly’s weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street’s expectations. The American pharmaceutical giant also saw strong
